| Identification | Back Directory | [Name]
2,3-dimethyl-2H-indazol-6-amine hydrochloride | [CAS]
635702-60-2 | [Synonyms]
PAZ20
Pazopanib Impurity 21
Pazopanib Impurity 7 HCl
2,3-Dimethyl-6-amino-2H-indazole Hy
2,3-Dimethyl-6-Amino-2H-Indazole HCl
2,3-dimethylindazol-6-amine hydrochloride
3-Methyl-6-nitro-1H-indazole hydrochloride
6-amino-2,3-dimethylindazole hydrochloride
3-diMethyl-2H-indazol-6-aMine hydrochloride
2,3-dimethyl-2H-indazol-6-amine hydrochloride
2,3-Dimethyl-6-amino-2H-indazole hydrochloride
6-Amino-2,3-dimethyl-2H-indazole Hydrochloride
2,3-Dimethyl-2H-indazole-6-amine hydrochloride
2H-Indazol-6-aMine,2,3-diMethyl-, hydrochloride
2,3-Dimethyl-2H-indazol-6-amine monohydrochloride
2H-Indazol-6-aMine,2,3-diMethyl-, hydrochloride (1:1)
2,3-dimethyl-2H-indazol-6-amine hydrochloride ISO 9001：2015 REACH
2,3-Dimethyl-2H-indazol-6-amine hydrochloride 2,3-Dimethyl-2H-indazol-6-amine monohydrochloride | [EINECS(EC#)]
200-001-8 | [Molecular Formula]
C9H12ClN3 | [MDL Number]
MFCD17014819 | [MOL File]
635702-60-2.mol | [Molecular Weight]
197.665 |
| Chemical Properties | Back Directory | [Melting point ]
>230°C (dec.) | [storage temp. ]
Inert atmosphere,Room Temperature | [solubility ]
DMSO (Slightly), Methanol (Slightly) | [form ]
Solid | [color ]
Pale Beige to Light Beige | [Stability:]
Hygroscopic | [InChI]
InChI=1S/C9H11N3.ClH/c1-6-8-4-3-7(10)5-9(8)11-12(6)2;/h3-5H,10H2,1-2H3;1H | [InChIKey]
DYTQJZDNKWQSLS-UHFFFAOYSA-N | [SMILES]
N1=C2C(C=CC(N)=C2)=C(C)N1C.[H]Cl |
| Hazard Information | Back Directory | [Description]
2,3-dimethyl-2H-indazol-6-amine hydrochloride is a pharmaceutical intermediate impurity, a by-product from the preparation of pazopanib hydrochloride, which can be used as an impurity standard solution for experimental analysis. | [Chemical Properties]
Powder | [Uses]
2,3-Dimethyl-6-amino-2H-indazole is an impurity in the synthesis of Pazopanib (P210925) hydrochloride, an oral angiogenesis inhibitor targeting VEGFR and PDGFR. | [Synthesis]
General procedure for the synthesis of 2,3-dimethyl-6-amino-2H-indazole hydrochloride from 2,3-dimethyl-6-nitroindazole: 2,3-dimethyl-6-nitro-2H-indazole (1.13 g) was dissolved in 2-methoxyethyl ether (12 mL) under stirring at 0°C, and then 4.48 g of stannous chloride in 8.9 mL of concentrated hydrochloric acid was added drop by drop over a period of 5 minutes solution. After the dropwise addition was completed, the ice bath was removed and the reaction mixture continued to be stirred for 30 minutes. Subsequently, about 40 mL of diethyl ether was added to the reaction solution to induce precipitation of the product. The precipitate was separated by filtration and washed with diethyl ether to afford the yellow solid product 2,3-dimethyl-6-amino-2H-indazole hydrochloride (1.1 g, 95% yield). The structure of the product was confirmed by 1H NMR (300 MHz, DMSO-d6) and mass spectrometry (ES+): 1H NMR δ 7.77 (d, J=8.9Hz, 1H), 7.18 (s, 1H), 7.88 (m, 1H), 4.04 (s, 3H), 2.61 (s, 3H); MS (ES+, m/z) 162 (M+H). | [References]
[1] Patent: WO2003/106416, 2003, A2. Location in patent: Page 42-43
[2] Patent: WO2007/64753, 2007, A2. Location in patent: Page/Page column 27
[3] Journal of Medicinal Chemistry, 2008, vol. 51, # 15, p. 4632 - 4640
[4] Patent: WO2006/20564, 2006, A1. Location in patent: Page/Page column 14
[5] Patent: EP2311825, 2015, B1. Location in patent: Paragraph 0178 - 0180 |
|
|